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Dendritic cells change IL-27 production 
pattern during childhood
Claudius U Meyer1*, Julia Birkholz1, Nadine Weins1, Aysefa Doganci1, Stephan Gehring1, Fred Zepp1  
and Markus Knuf2
Abstract 
Background: Interleukin-27 (IL-27) has been described to be highly expressed during the very first days after birth, 
but secretion of IL-27 by dendritic cells during the course of childhood has not been described.
Findings: In our present study we enrolled children (n = 55) in the range from 1 day of to 18 years of age and asked 
for a small whole blood sample. The capacity of dendritic cells to produce IL-27 during childhood was measured after 
whole blood culture with or without inflammatory stimuli. Results support recent findings of high IL-27 levels after 
birth and lowest levels in adults. Interestingly, we detected an interim peak production level at early adolescence.
Conclusion: These data hint to prominent roles of IL-27 at the very start of post-natal life. Furthermore, a link has 
been given to so far not described immunological events during puberty.
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Findings
Telling basic research immunologists, that a human new-
born has difficulties to produce interleukin-12 (IL-12) 
leaves them with quite some astonishment. The generally 
accepted model is, that IL-12 is a pivotal and necessary 
factor to induce a sufficient and specific Th1-polarized 
cellular immune response against viral pathogens. Recent 
pediatric studies indicate that the capacity of dendritic 
cells, the main producers of IL-12 in adults, only reaches 
adult-like levels until close to the beginning of adoles-
cence [1]. During the first months of life the substantial 
lack of IL-12 expression results in the well-known Th2-
biased neonatal T cell immune response.
Another family member of IL-12-like cytokines, IL-27, 
has been recognized not only as an inhibiting factor to 
various T helper cell subsets, but also as a cytokine with 
a pronounced capacity to induce Th1 polarization, thus 
having the potential to physiologically support or be in 
place of IL-12, at least in part. Recently, we identified 
exceptionally high levels of IL-27 expression of dendritic 
cells derived from neonates [2]. To further character-
ize IL-27 production during childhood we collected 
whole blood samples from children aged between 0 and 
18 years and investigated the capacity of dendritic cells to 
produce IL-27.
At the University Medical Center Mainz and at the 
Dr. Horst-Schmidt-Kliniken Wiesbaden for this obser-
vational study we enrolled 55 healthy subjects aged 
0–18  years after. Additionally, samples from five adult 
volunteers were collected as a control group. The study 
has been approved by the local ethical board of the 
Dr. Horst-Schmidt-Kliniken Wiesbaden. We received 
informed consent from the parents of all subjects and 
additionally from those subjects older than 12  years of 
age. The adult participants gave informed consent for a 
blood withdrawal. The heparinized whole blood sam-
ples were collected, and processed within 2  h after col-
lection. Briefly, whole blood samples were diluted with 
culture medium. Diluted cell suspensions were cultivated 
for 6 h at 37°C and 5% CO2 in the presence or absence of 
the stimulators IFNγ (50 µg/ml; Strathmann Biotec), LPS 
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(10  µg/ml; InvivoGen), IFNγ  +  LPS, PolyIC (25  µg/ml; 
InvivoGen), ssRNA (5 µg/ml; InvivoGen) or SEB (10 µg/
ml; Sigma Aldrich). To detect the capacity to express 
IL-27, dendritic cells were identified using flow cytom-
etry (LSR II, BD Biosciences) by antibody labeling of the 
cell surface markers CD14, HLADR, CD11c and CD123 
(all BD Biosciences) combined with an intracellular stain-
ing procedure for detection of IL-27-positive dendritic 
cells (Additional file 1). Frequencies of myeloid Dendritic 
Cells (mDCs; CD14−HLADR+CD11c+) and plasmacy-
toid Dendritic Cells (pDCs; CD14−HLADR+CD123+) 
were determined (Additional file 2: Figure S2). Percent-
age of IL-27-positive mDCs and pDCs were assessed 
using intracellular staining with anti-IL-27 antibody 
(R&D Systems; anti-EBI3). Furthermore we analyzed the 
IL-27 plasma concentration in a subset of the study group 
using ELISA (Additional file 1).
Whole blood collection from 41 subjects resulted in eli-
gible sample volumes of at least 1 ml heparinized whole 
blood. Drop outs were related to technical difficulties to 
collect sufficient whole blood volume from neonates and 
very young infants. The frequency of both, mDCs and 
pDCs within the leukocyte population were stable during 
childhood, except for a slight decrease of less than three 
percent during the very first months after birth (Addi-
tional file 3: Figure S3). In contrast, high numbers of IL-
27-positive mDCs were detected immediately after birth. 
In the following weeks and months these IL-27-positive 
mDC frequencies considerably decreased. Interest-
ingly, during childhood and in contrast to an anticipated, 
rather linear decline over time, a second maximum was 
reached with a peak around the age range of 10–12 years. 
Our observation in adolescents and adults revealed, that 
IL-27 production levels were at lowest levels within the 
investigated cohort. This developmental kinetic was 
clearly detectable in unstimulated mDCs. Any of the 
used stimulators only slightly—if at all—modulated 
the underlying frequency of IL-27-positive mDCs with 
IFNγ  +  LPS being the most potent positive modulator 
(Figure 1a). pDCs presented with very low levels of IL-27 
expression, specifically with no biphasic characteristics 
and no discernible difference regarding neonatal versus 
adult IL-27 levels (Figure 1a). IL-27 serum levels reached 
maximum levels in early adolescence in accordance with 
bisphasic IL-27-positive mDC frequencies (Figure 1b).
Comprehensive data have been accumulated on the 
limited expression of IL-12 in neonates [1, 3]. A contrib-
uting molecular mechanism of the latter phenomenon 
involves the histone component MUC2, which inhibits 
the accessibility of the il12p35 gene [4]. Consequently, 
there is an obvious need for a compensating functional 
equivalent. Recent reports suggested several ways how 
IL-27 might be involved in STAT1-mediated Th1-like, e.g. 
antiviral immune responses [5]. IL-27 has been shown to 
induce the expression of the transcription factor T-bet, 
a gatekeeper factor for the transactivation of IFNγ and 
the IL-12ß2 receptor [6, 7]. This might foster a low level 
Th1 activity even in the presence of the minuscule levels 
of IL-12 seen in neonates. Moreover IL-27 plays a role in 
the generation of cytotoxic T cells, thus stimulating the 
expression of granzyme B in CD8+ T cells leading to aug-
mentation of type 1 cell-mediated immunity. In addition, 
IL-27 is involved in the induction of regulatory T cells, 
like Tr1 and Tregs [8], and promotes the secretion of the 
Th2-cytokine IL-10 [9], all arguing for a role of IL-27 in 
ameliorating inflammatory processes.
Our finding of high IL-27 levels in early life might 
reflect the particular challenge of neonates adapting to 
Figure 1 a Age-related frequencies of mDCs and pDCs producing  
IL-27. Age-based simple moving mean was applied as a trend 
indicator (see Additional file 4: Figure S4) to identify age-related 
differences in the capacity to produce IL-27 during childhood. 
Individual percentage of IL-27-positive mDCs were based on 
the CD14−HLADR+CD123−CD11c+ population for mDCs and 
CD14−HLADR+CD123+CD11c− for pDCs (n = 41). b Age-related 
concentrations of IL-27 in plasma of peripheral blood. From a sub-set 
of subjects plasma was collected to test the concentration of IL-27. 
Levels of IL-27 in children less than 1 year of age were slightly higher 
as in adults, but considerably lower than IL-27 concentrations in the 
age groups between >1 and <18 years of age, with a maximum at 
about 6–12 years of age. (n > 5; except: 0–1 years, n = 12).
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the rapidly changing microbial community that starts 
developing immediately after birth. In a mutual interac-
tion host immunity and the micro-flora starts to develop. 
The high levels of IL-27 in neonates coincided with the 
time period of maximum susceptibility for infectious dis-
eases in childhood underpinning a critical role IL-27 may 
play. The presence of IL-27 correlates with the integrity 
of the mucosal lining and the resistance to translocation 
of microbes from the gut to the circulation [10].
A time frame in childhood with a second peak of ele-
vated IL-27 expression was unanticipated. Interestingly, 
this developmental trait was not related to plasmacytoid 
cells, but otherwise it was also detectable when test-
ing for IL-27 protein concentrations in peripheral blood 
plasma. To our knowledge, this observation has not been 
reported so far and in the light of the current literature 
focusing on the immune system of the developing child. 
Further investigations are prompted, linking this obser-
vation to other developmental patterns or disease dispo-
sitions in this age range.
In conclusion, our data on IL-27 indicate that during 
childhood development IL-27 does not represent a sim-
ple opposing trend to the IL-12 kinetics, but points to a 
more complex, yet in many details unknown regulative 
context.
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